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Abstract: The aim of the study was to examine changes in health-related quality of life among 
older adults undergoing cardiac resynchronization therapy (CRT), a pacemaker based inter-
vention for heart failure. Twenty-one patients (mean age = 68; SD = 8) completed measures 
of cardiovascular health and quality of life prior to and 3-months post-CRT. Following the 
intervention, patients reported improvements in their perception of their physical functioning 
(t = 2.8, p   0.01) and feelings of vitality (t = 2.9, p   0.01) on the MOS SF-36 Health Sur-
vey. Patients improved on objective clinical measures of exercise capacity, cardiac ejection 
fraction, and ventricular dyssynchrony. Younger patients reported greater improvements in 
physical functioning and decreases in pain. Higher baseline body mass index was associated 
with less improvement in physical functioning. Finally, patients with nonischemic heart failure 
reported greater improvements on multiple subscales of the SF-36 than patients with ischemic 
heart failure. This preliminary study documented improvements in health-related quality of life 
following CRT. The ﬁ  ndings highlight that speciﬁ  c patient characteristics may be associated 
with quality of life changes. Future studies will beneﬁ  t from including quality of life measures 
that assess multiple health-related domains.
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Introduction
Heart failure is one of the leading chronic illnesses that impacts quality of life (Alonso 
et al 2004). In addition to decreasing general well-being, there is evidence that poor 
health-related quality of life is a predictor of subsequent hospital admission and death 
among elderly patients with heart failure (Ho et al 2005; Rodriguez-Artalejo et al 2005). 
The high prevalence and broad impact of heart failure underscores the importance 
of understanding how treatment interventions relate to patient outcomes, including 
improvements in quality of life.
Cardiac resynchronization therapy (CRT) is a recently developed pacing therapy   
for patients with refractory heart failure who demonstrate symptomatic ventricular 
dyssynchrony. CRT has been shown to improve heart failure-speciﬁ  c quality of life, 
along with multiple clinical endpoints including heart failure symptoms, exercise 
capacity, hospitalization rates, and longevity (Abraham 2003; Bradley et al 2003). 
Heart failure-speciﬁ  c quality of life, as measured by the Minnesota Living with Heart 
Failure Questionnaire (LHFQ), reﬂ  ects self-reports of the extent to which heart failure 
symptoms prevent individuals from living as they would like (Rector et al 1987a). Heart 
failure-speciﬁ  c quality of life combines physical, socioeconomic, and psychological 
impairments into a single dimension. Improvements in heart failure-speciﬁ  c quality 
of life have been observed from one month to one year following CRT (Cazeau et al 
2001; Abraham et al 2002; Gras et al 2002; Abraham 2003).Clinical Interventions in Aging 2008:3(3) 554
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Relatively little is known about the impact of CRT on 
different domains of more general health-related quality of 
life. Health-related quality of life, as assessed by the MOS 
SF-36, is not disease speciﬁ  c and captures quality of life 
in multiple domains (ie, physical functioning, pain, social 
functioning, mental health, and general health perceptions). 
Patients with heart failure experience decline in multiple 
aspects of quality of life, not just physical functioning (Hobbs 
et al 2002). Among the few trials examining the impact of 
CRT on health-related quality of life, Skobel and colleagues 
(2005) reported that CRT produced improvements in multiple 
domains. The improvements were particularly evident in 
those with Cheyne-Stokes respiration (CSR). This ﬁ  nding 
illustrates that patients with different clinical characteris-
tics may experience differential changes in quality of life 
following CRT.
Factors that might relate to improvements in quality of life 
following CRT remain unidentiﬁ  ed. In one study that focused 
on heart failure-speciﬁ  c quality of life, Krahn and colleagues 
(2002) examined several patient characteristics to explain why 
some patients undergoing CRT demonstrated improvement in 
their heart failure symptoms while others did not. The authors 
examined age, sex, heart failure etiology, QRS width, ejec-
tion fraction, and heart failure severity (ie, New York Heart 
Association Class I-IV; higher classes reﬂ  ect greater physical 
limitation). No associations were found between quality of life 
improvement and these factors. Despite this negative ﬁ  nding 
in heart failure-speciﬁ  c quality of life, it is possible that there 
are factors that relate to improvements in other domains of 
health-related quality of life. For example, certain patients 
may be more likely to perceive improvements in their general 
physical health, social functioning, or emotional functioning 
following CRT than other patients.
The aim of the current study was to examine changes in 
health-related quality of life following CRT among older 
adults with Class II-IV heart failure. We sought to extend 
previous ﬁ  ndings of improvement in heart failure-speciﬁ  c 
quality of life by examining quality of life in a broader range 
of health-related domains. A secondary objective of the study 
was to identify patient characteristics that might relate to 
improvement in speciﬁ  c quality of life domains.
Methods
Study sample
The current study included 24 older adults with heart failure 
who were candidates for cardiac resynchronization therapy. 
Patients were recruited through the arrhythmia services 
division of cardiology in a major teaching hospital. All 
participants were enrolled in a larger, prospective study of 
physiological and psychological changes following cardiac 
resynchronization therapy. To be enrolled in the study, indi-
viduals were required to be over the age of 55, have NYHA 
Class II-IV heart failure, cardiac ejection fraction below 
35%, and QRS duration greater than or equal to 130 ms. 
Consistent with aims of the parent study, exclusion criteria 
were as follows: 1) previous diagnosis with a cognitive 
disorder including dementia or mild cognitive impairment, 
2) neurological disorder, 3) major psychiatric disorder such 
as schizophrenia, bipolar illness, or substance abuse, or 4) 
current untreated major depressive episode.
Of the 24 participants who completed the baseline assess-
ment, 3 did not return for follow-up. During the follow-up 
window, 2 participants experienced lead displacement and 
underwent revision of their device. One of these individuals 
was included in the follow-up and one reported being too 
tired to return for the ﬁ  nal study visit. The other participant 
who withdrew from the study indicated that he was unable 
to return due to transportation concerns. Overall, this repre-
sents an 88% retention rate. Data analyses were based upon 
the ﬁ  nal sample of 21 participants with complete baseline 
and 3-month follow-up data. The demographic and clinical 
characteristics of the sample are presented in Table 1.
Procedure
The study was approved by the local Institutional Review 
Board and all patients provided written informed consent 
before enrollment. The baseline study visit was conducted 
within the 2 weeks before implantation of the biventricular 
(BiV) pacemaker/implantable cardioverter deﬁ  brillator (ICD; 
note: 1 patient received a BiV device without a deﬁ  brillator). 
During the baseline visit, participants completed a medical 
history interview. Medical history variables were coded as 
either present or absent according to participants’ self-report 
and were conﬁ  rmed by a medical chart review. Medical and 
cardiovascular health was assessed using electrocardiogram, 
echocardiogram, and the 6-minute walk test (ATS Board of 
Directors 2002). The baseline echocardiogram, 6-minute 
walk test, and quality of life measures were completed dur-
ing the baseline study visit within 2 weeks of the implant. 
All other clinical measures were obtained within the month 
before the implant and were collected via medical chart 
review. The follow-up echocardiogram, 6-minute walk test, 
and quality of life measures were completed during a study 
visit approximately 3-months after BiV/ICD implantation. 
The average length of follow-up after BiV/ICD implantation 
was 89 days (SD = 13).Clinical Interventions in Aging 2008:3(3) 555
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Measures
Electrocardiogram
Electrocardiogram was used to quantify the degree of intra-
ventricular dyssynchrony. QRS complex duration expressed 
in milliseconds was the primary variable of interest.
Echocardiogram
Two-D transthoracic echocardiograms were performed 
with an IE33 machine (Philips, Andover, MA) according 
to American Society of Echocardiography standards. Left 
ventricular ejection fraction was calculated based upon 
biplane volumes. (EF = EDV − ESV/EDV). The biplane 
method of discs utilized two orthogonal views from the 
apex; it calculated volumes from summation of areas from 
diameters of 20 cylinder discs of equal height. The discs were 
apportioned by dividing the chamber’s longest length into 20 
equal sections. In 3 participants, a single plane method from 
the apical 4-chamber view was employed due to suboptimal 
image quality.
6-minute walk test
The 6 minute walk test was used as a measure of functional 
capacity. It has been widely used to measure the response to 
interventions in moderate to severe pulmonary and cardiac 
Table 1 Baseline demographic and clinical characteristics of sample
Patient characteristics  Percent  Mean (SD)  Range
Demographics    
  Age (years)    67.9 (8.4)  56–84
  Sex (% female)  19% (4/21)   
  Education (years)    12.2 (3.7)  5–18
Baseline lab measures    
  Systolic BP (mmHg)    128.7 (13.9)  108–160
  Diastolic BP (mmHg)    73.9 (9.8)  60–90
  Body mass index (kg/m2)  24.2  (6.9)  13.8–41.6
  Blood glucose (mg/dl)    140.6 (51.2)  91–262
  Blood urea nitrogen (mg/dl)    18.2 (9.2)  7–41
  Creatinine (mg/dl)    1.1 (0.3)  0.6–1.7
  Beta natriuretic peptide (pg/ml)    205.3 (238.9)  16.7–939.7
Medical history information    
 Hypertension  67%  (14/21)   
 Hypercholesterolemia  71%  (15/21)   
  Type 2 diabetes mellitus  38% (8/21)   
  History of smoking  67% (14/21)   
  Prior myocardial infarction  52% (11/21)   
  History of atrial ﬁ  brillation  33% (7/21)   
  Percutaneous coronary intervention  52% (11/21)   
  Coronary artery bypass surgery  14% (3/21)   
  Previous ICD  10% (2/21)   
  Valve surgery  5% (1/21)   
  Heart failure etiology     
  Ischemic  48%  (10/21)   
  Nonischemic  52%  (11/21)   
  NYHA Heart Failure Class     
  Class  II  55%  (11/21)   
    Class III and IV*  45% (9/21)   
 Medications     
  Beta  blockers  95%  (20/21)   
  Aspirin/antithrombotics  81%  (17/21)   
    Lipid lowering agents  76% (16/21)   
    ACE inhibitors  76% (16/21)   
  Diuretics  67%  (14/21)   
  Digoxin  43%  (9/21)   
  Hypoglycemics  33%  (7/21)   
  Antidepressants/antianxiety  33%  (7/21)   
  Vasodilators  29%  (6/21)   
Notes: *Class III and IV were grouped for analytic purposes because 1 person was Class IV.Clinical Interventions in Aging 2008:3(3) 556
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disease (Enright 2003). The test was administered consistent 
with the American Thoracic Society guidelines (ATS Board 
of Directors 2002). Total distance walked in feet in six min-
utes was the outcome measure.
Beck depression inventory-II (BDI-II)
The BDI-II (Beck et al 1996) is a 21-item self-report 
questionnaire measuring severity of depressive symptoms. 
Respondents were asked to endorse statements characteriz-
ing their mood. The maximum total score is 63, with scores 
greater than 14 suggesting clinically signiﬁ  cant depressive 
symptoms.
Minnesota living with heart failure questionnaire 
(LHFQ)
The LHFQ is a 21-item self-report measure (Rector et al 
1987b). Respondents were asked to rate the extent to which 
heart failure speciﬁ  c symptoms prevented them from living 
as they wanted within the past month on a 6-point Likert 
scale (Rector and Cohn 1992; Bennett et al 2002).
Medical outcome study short-form general health 
survey (SF-36)
The SF-36 is a 36-item health status and quality of life inven-
tory (Ware and Sherbourne 1992) developed to measure 
health concepts across different age, disease, and treatment 
groups. Respondents indicated the degree or frequency of 
problematic health, behavioral, and emotional events on a 
Likert scale. The SF-36 assesses health status in eight areas: 
physical functioning, role disruption due to physical difﬁ  -
culties, role disruption due to emotional difﬁ  culties, social 
functioning, mental health, vigor, health perception, and pain. 
Scores on the subscales range from 0 to 100. The measure has 
good validity and reliability and has been extensively used in 
healthy and medical populations (McHorney et al 1993).
Data analysis
Descriptive statistics regarding the sample demographic 
and medical characteristics were calculated and are pre-
sented in Table 1. The primary analysis to examine change 
in health-related quality of life included eight paired t-tests 
to compare patients’ self-reported quality of life on each 
of the SF-36 scales at baseline and 3-months post-CRT. 
To examine change in the patients’ heart failure symptoms 
and cardiovascular health, paired t-tests were calculated 
comparing baseline and follow-up values on the LHFQ, 6 
minute walk test, ejection fraction, and QRS duration form 
electrocardiogram.
A secondary aim of the study was to examine individual 
difference variables that might be associated with changes in 
quality of life following CRT. Age, body mass index (BMI), 
heart failure severity measured by NYHA heart failure class 
(ie, Class II vs. Class II and IV), heart failure etiology (ie, 
ischemic vs nonischemic), change in ejection fraction and 
QRS duration from baseline to follow-up were examined. For 
the secondary analyses, the eight SF-36 subscale scores were 
converted into standardized z-scores. Baseline z-scores were 
subtracted from follow-up z-scores to create a change score 
for each SF-36 subscale. Thus, positive change scores indi-
cate improvement in quality of life after CRT and negative 
change scores indicate a decline in quality of life following 
CRT. Bivariate correlations were calculated between the con-
tinuous variables (ie, age, BMI, change in ejection fraction 
and QRS duration) and SF-36 change scores. Independent 
samples t-tests were used to compare change in quality of life 
for the dichotomous variables (ie, heart failure etiology and 
NYHA class). Data were analyzed using SPSS 11.0 software. 
Given the exploratory nature of the study, an alpha level of 
0.05 was set a priori for all analyses.
Results
Paired t-tests comparing baseline and follow-up scores 
on the SF-36 for the entire sample revealed that patients 
reported statistically significant improvements on the 
physical function (t = 2.8, df = 20, p   0.01) and vitality 
(t = 2.9, df = 20, p   0.01) subscales (see Table 2). The 
decline in LHFQ score approached statistical signiﬁ  cance 
(t = 1.9, p   0.07). Consistent with the inclusion criteria, 
the average BDI-II score for the sample suggested minimal 
symptoms of depression at baseline and follow-up. Regard-
ing the clinical measures, paired t-tests showed that there 
was a signiﬁ  cant increase in 6-minute walk distance (1249 
ft vs 1150 ft; t = 1.9, df = 18, p = 0.02), increase in ejection 
fraction (30% vs 39%; t = 3.9, df = 20, p   0.01), decrease 
in end diastolic (174 vs 146; t = 3.8, df = 15, p   0.01) and 
systolic volumes (123 vs 94; t = 6.2, df = 15, p   0.001), 
and decrease in QRS duration (162 vs 143; t = 3.0, df = 20, 
p = 0.001) following CRT.
The secondary analyses to examine the potential impact 
of clinical characteristics on change in health-related qual-
ity of life revealed differential changes in quality of life for 
several variables. Correlation analyses revealed that age was 
signiﬁ  cantly associated with change on the physical func-
tion subscale (r = −0.65, p   −0.01) and the pain subscale 
(r = −0.58, p   0.01). Speciﬁ  cally, younger patients tended 
to report greater improvement in physical functioning and Clinical Interventions in Aging 2008:3(3) 557
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greater decreases in bodily pain following CRT (see Table 3). 
Figure 1 illustrates the association between age and changes 
in physical function. Correlation analysis also revealed 
that higher baseline BMI was associated with signiﬁ  cantly 
less improvement in physical functioning following CRT 
(r = −0.44, p   0.05). Change in ejection fraction and 
change in QRS duration were not signiﬁ  cantly associated 
with change on any of the quality of life scales. Patients with 
nonischemic heart failure reported greater improvements on 
the physical function, vitality, general health perception, and 
social function subscales following CRT than patients with 
ischemic heart failure (see Table 2). Finally, patients with 
Class II heart failure at baseline reported greater improvement 
on the mental health subscale following CRT than patients 
with Class III and IV heart failure at baseline (+0.8 vs. −0.2 
z-score change; t = 2.5, df = 19, p   0.05).
Discussion
The results of the current study provide two important 
advances to the current literature on quality of life following 
CRT. First, the present ﬁ  ndings suggest that on average, CRT 
improves general health-related quality of life, particularly in 
Table 2 Change on clinical and psychosocial measures following CRT
Measure Total sample mean
score (SD) (n = 21)
Nonischemic HF
z-score change (n = 11)
Ischemic H
z-score change (n = 10)
Sig.
Baseline Follow-up Sig.   
SF-36
 Physical  function 56.2 (23.7)** 65.5 (24.8)** t = 2.8 +0.7* +0.1* t = 2.3
   Role-physical function 52.5 (41.3) 58.7 (40.8) +0.6 −0.3
  Pain index 69.0 (24.1) 75.9 (22.5) +0.6 −0.1
   General health perception 55.5 (22.7) 64.1 (21.7) +0.9* −0.2* t = 2.3
 Vitality  score 51.1 (18.6)** 64.0 (23.6)** t = 2.9 +1.19** −0.1** t = 2.8
  Social function 81.5 (22.9) 82.7 (26.4) +0.6* −0.6* t = 2.1
   Role-emotional function 63.3 (38.8) 70.0 (35.7) +0.6 −0.2
   Mental health index 74.5 (16.3) 80.6 (17.8) +0.4 +0.3
MLHF questionnaire 30.6 (24.3) 21.7 (23.9)
Beck Depression Inventory-II 7.3 (6.4) 5.8 (6.5)
Echocardiogram
   Ejection fraction (%) 30.0 (8.8)*** 39.2 (9.0)** t = 5.4
   LV end diastolic volume 174.1 (76.2)** 146.3 (74.5)** t = 3.8
   LV end systolic volume 123.6 (72.4)*** 94.1 (67.2)*** t = 6.2
Electrocardiogram
  QRS duration (ms) 163.4 (17.0)*** 144.1 (14.5)*** t = 3.9
6-Minute Walk Test (feet) 1150.0 (279.1)* 1248.9 (345.2)* t = 2.7     
Notes: *p   0.05, **p   0.01.
Abbreviations: LV, left ventricular; HF, heart failure.
Table 3 Intercorrelations between clinical variables and change in health-related quality of life domains
MOS SF-36 domain change  Age  Baseline body mass index  Ejection fraction change  QRS duration change
Physical function  −0.65**  −0.44* 0.11  −0.21
Role-physical function  −0.10 0.11  −0.03  −0.15
Pain index  −0.58**  −0.20 0.01  −0.37
General health perception  −0.19 0.04  −0.12  −0.25
Vitality  −0.26 0.03  −0.06  −0.30
Social function  −0.19 0.03  −0.22  −0.31
Role-emotional function  −0.21 0.24  0.01  −0.21
Mental health index  −0.09 0.01  −0.15  −0.16
Notes: *p   0.05, **p   0.01.Clinical Interventions in Aging 2008:3(3) 558
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the domains of physical functioning and feelings of vitality. 
Additionally, the results suggest that the areas of quality of 
life that improve may depend on, or at least relate to, certain 
patient characteristics. That is, certain subsets of patients may 
be more likely to experience quality of life improvements 
than others.
Younger patients were more likely to perceive an 
improvement in physical functioning and level of pain than 
older patients after CRT. This ﬁ  nding is consistent with the 
results of a recent study of pacemaker implantation in patients 
with arrhythmia (Fleischmann et al 2006). Fleischmann and 
colleagues (2006) found that patients older than 75 years 
experienced less improvement in physical functioning 
than younger subjects. Several clinical trials of CRT have 
examined age effects on clinical measures of heart failure 
and have observed similar beneﬁ  ts in mortality, ventricular 
dyssynchrony and ejection fraction for patients above and 
below the median age of the sample (eg, Cleland et al 2005, 
cut at age 66; Bleeker et al 2005, cut at age 70); thus, it is 
notable that we observed age effects in relation to general 
health-related quality of life in the current study of CRT. We 
examined age as a continuous variable rather than using an 
age cutoff, and this may have increased our ability to detect 
age effects on perceived improvement in health-related 
quality of life.
Patients with nonischemic heart failure reported greater 
improvements on a number of domains of health-related 
quality of life (ie, physical function, vitality, general health 
perception, and social function) than patients with ischemic 
heart failure. Patients with higher BMIs at baseline reported 
less improvement in their physical functioning. Although it 
is not possible to determine the reason for these differences 
based upon the current data, one potential hypothesis is that 
patients with ischemic heart failure and higher BMIs have 
additional medical concerns that serve to maintain poorer 
general health-related quality of life after CRT.
We also examined the potential association between 
change in cardiac ejection fraction and QRS duration after 
CRT and improvements in quality of life; however, these 
variables were not signiﬁ  cantly associated with change on 
any of the quality of life subscales. Post-hoc examination 
of the data revealed that ejection fraction and QRS duration 
also was not associated with self-reported quality of life at 
the baseline assessment. It is possible that the small sample 
size limited our ability to identify a potential association, but 
this is unlikely, since physiological measures such as ejection 
fraction and mitral valve regurgitation have not been associ-
ated with patients’ perceived quality of life in several previ-
ous studies (Rector and Cohn 1992; Hauptman et al 2006). 
Larger longitudinal studies are needed to conﬁ  rm the lack of 
an association, but the ﬁ  nding may reﬂ  ect the fact that patient 
perceptions of function are complex and likely determined 
by interactions between individual differences in behavioral, 
cognitive, and emotional factors and disease severity.
Figure 1 Intercorrelation between age and change in SF-36 Physical Function Score.
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By design, the study included patients with Class II-IV 
heart failure who were free of neurological and major psy-
chiatric disorders. Several previous trials of CRT have 
focused on patients with Class III and IV heart failure; thus, 
our sample is somewhat healthier than these previous trials. 
Replication of the current ﬁ  ndings in a sample including 
more patients with Class IV heart failure will be helpful to 
strengthen the generalizability of the ﬁ  ndings. Importantly, 
the inclusion of patients with Class II heart failure allowed us 
to examine changes in quality of life comparing patients with 
Class II and Class III/IV heart failure at baseline. Patients 
with Class II heart failure reported greater improvement 
on social functioning than those rated as Class III and IV, 
and there were no signiﬁ  cant differences in magnitude of 
improvement on the other SF-36 quality of life domains. This 
suggests that patients with Class II heart failure beneﬁ  ted 
at least equivalently from CRT in terms of their perceived 
improvement in general health-related quality of life.
The current study had some limitations that are impor-
tant to consider. First, the sample size was fairly small, and 
as a result the ﬁ  ndings should be considered preliminary. 
The study was designed with a 3 month follow-up based 
on previous research suggesting that improvements in heart 
failure-speciﬁ  c quality of life have been observed as early as 
1–3 months (Cazeau et al 2001; Abraham et al 2002; Gras 
et al 2002). The current ﬁ  ndings could have been extended 
by following patients for a longer period of time to examine 
the long-term effects of CRT on health-related quality of life. 
However, the 3 month time period coincides with signiﬁ  cant 
improvement in cardiac function following CRT (Abraham 
2003), suggesting that this time period is appropriate to 
observe effects on health-related quality of life.
Although previous large clinical trials of CRT have 
included brief measures of quality of life, typically deﬁ  ned 
using the LHFQ, the current study is among the ﬁ  rst to 
examine changes in the more general construct of health-
related quality of life. We found that patient perceptions of 
their physical functioning and vitality improved 3 months 
after CRT. Given the speciﬁ  c focus on changes in quality 
of life after CRT, we analyzed several clinical variables 
in relation to changes in quality of life and found that age, 
baseline BMI, and heart failure etiology (ie, ischemic vs. 
nonischemic) were associated with differential improvement 
in health-related quality of life. The fact that several patient 
characteristics were associated with changes in quality of life 
following CRT points to the importance of examining patient 
characteristics such as age and medical comorbidities that 
may predict who will experience the greatest improvement 
in their perceived health, vitality and social functioning. 
Larger clinical trails should include broader measures of 
quality of life, in order to elucidate the impact of CRT on 
aspects of patient well-being that go beyond the patients’ 
perception of how heart failure speciﬁ  c symptoms impact 
their functioning.
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